Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Aveeno Daily Moisturising Sheer Hydration Lotion is a topical emollient formulation designed to hydrate and protect the skin barrier. Its primary active ingredient is prebiotic colloidal oatmeal (Avena sativa), which is known for its skin-soothing properties and ability to restore the skin's natural moisture barrier. The Sheer Hydration variant is specifically formulated to be lightweight and absorb quickly, providing 24-hour moisture without a heavy or greasy feel. In clinical research, it has been used as a comparator to prescription barrier repair creams like EpiCeram in patients with atopic dermatitis to evaluate its effect on transepidermal water loss (TEWL) and skin barrier function.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Aveeno Daily Moisturising Sheer Hydration Lotion (Johnson & Johnson).